Related Experiment Video
Updated: Jun 5, 2026
02:28
Measuring Psoriasis Severity at Home
Published on: March 1, 2024
Pharmacogenetics of psoriasis.
Darren D O'Rielly1, Proton Rahman
1Department of Pathology & Molecular Medicine, Kingston General Hospital & Queen's University, Kingston, ON, Canada.
Pharmacogenomics
|December 23, 2010
Summary
Psoriasis pharmacogenetics explores genetic factors influencing treatment response. Identifying genetic variants can personalize psoriasis therapy, improving outcomes and reducing costs.
Area of Science:
- Dermatology
- Genetics
- Pharmacology
Background:
- Psoriasis is a chronic inflammatory skin disease with significant genetic influence.
- Treatment efficacy for psoriasis varies greatly among individuals.
- Pharmacogenetics offers insights into personalized psoriasis treatment.
Purpose of the Study:
- To review the clinical aspects of psoriasis.
- To discuss the genetic susceptibility to psoriasis.
- To highlight current genetic targets for psoriasis pharmacotherapy.
Main Methods:
- Literature review of clinical psoriasis studies.
- Analysis of genetic predisposition research in psoriasis.
- Survey of emerging pharmacogenetic targets for psoriasis treatment.
Main Results:
- Psoriasis exhibits a strong genetic component influencing disease development.
- Genetic variations impact patient response to psoriasis pharmacotherapy.
- Pharmacogenetics is crucial for tailoring psoriasis treatment strategies.
Conclusions:
- Understanding psoriasis genetics is key to personalized medicine.
- Pharmacogenetic approaches can optimize psoriasis treatment efficacy.
- Future research should focus on identifying and validating genetic targets for psoriasis therapy.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...